Date: 4 November 2025
Venue: British Academy, 10-11 Carlton House Terrace, London SW1Y 5AH, United Kingdom
Register via this link: https://forms.cloud.microsoft/r/AsgsurkTEu
This workshop is designed to:
- Create a collaborative space for policymakers, researchers, patients, and funders to co-develop fair and practical solutions.
- Share real-world examples and international perspectives to promote meaningful interaction.
- Identify barriers and craft actionable, innovative solutions across sectors.
- Bridge grassroots insights with policy discussions to drive real progress in access to life-saving antibiotics.
Agenda for “Framing JUST solutions for ACCESS to treatment against AMR”
| Time | Topic | Speaker |
| 9.00 -9.10 am | Introduction – need for equitable access to antibiotics | Dr Alexandra Cameron Senior Expert, AMR Division, WHO |
| 9.10 – 9.20 am | Setting the scene – Barriers to accessing novel antibiotics in countries with high burden of bacterial antimicrobial resistant infections | Dr Mo Yin Deputy Director ADVANCE ID National University of Singapore |
| 9.20 – 10.00 am | Case studies | |
| 9.20 – 9.30 am | Compromised access - responding to and managing antibiotic shortages | Dr Esmita Charani Associate Professor University of Cape Town, South Africa |
| 9.30 – 9.40 am | Access to new medicines (newly approved drugs that are still not registered in majority LMICs) | Dr Sotharith Bory Chief of Medicines dept and ID unit – Calmette hospital, Cambodia |
| 9.40 – 9.50 am | Challenges in research and development of new drugs | Ms Takuko Sawada Vice-Chair, Shionogi & Co., Ltd Osaka, Japan |
| 9.50 – 10.00 am | Patient perspectives – leading advocacy efforts | Ms Susan Charles Task Force of AMR Survivors, United Kingdom |
| 10.00 -10.20 am | Break | |
| 10.20 – 10.30 am | Local policymaker – strategies on enabling access to treatment in local context | Dr Inke Nadia Assistant Professor Universitas Sumatera Utara Medan, Indonesia |
| 10.30 – 10.40 am | Global Health actor – Strategies on implementation of antibiotic access policies at regional/global level | Dr Kim Uhjin Regional advisor for Medical products WHO SEARO, India |
| 10.40 -10.50 am | Funder - the funded projects and their respective outcomes | Mr Rahul Dwivedi Serious Bacterial Infections Access leader (GARDP), Geneva |
| 10.50 – 11.00 am | Ensuring Pharmaceutical Accountability for Human Rights and Access to Medicines | Dr Katrina Perehudoff Faculty of Law, University of Amsterdam |
| 11.00 – 12.00 pm | Panel discussion followed by QnA | Speakers plus Moderator |
| 12.00 - 1.00 pm | Lunch Break | |
| 1.00 – 1.30 pm | Group activity – discussion of local barriers for antibiotic access | |
| 1.30 – 2.00 pm | Group discussion with post-it activity (queries brought forward to this session) | |
| 2.00 – 2.45 pm | Reform groups with individual topics identified in previous session | |
| 2.45 – 3.45 pm | Representatives exchange the solutions | |
| 3.45 – 4.00 pm | Break | |
| 4.00 – 4.30 pm | Wrap up |
